Siena, Italy

Maria Aricò

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 33(Granted Patents)


Location History:

  • Siena, IT (2012 - 2016)
  • Poggibonsi, IT (2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Maria Aricò: Innovator in Meningococcal Vaccine Development

Introduction

Maria Aricò is a prominent inventor based in Siena, Italy, known for her significant contributions to the field of vaccine development. With a total of four patents to her name, she has focused her research on improving the efficacy of meningococcal vaccines. Her innovative approaches aim to address critical gaps in vaccine coverage.

Latest Patents

One of her latest patents involves combinations of meningococcal factor H binding proteins. The invention addresses the poor coverage offered by the M01573 sequence of meningococcal fHbp in vaccines. In the first aspect of this patent, a fHbp-based vaccine includes two family I fHbp sequences, one closely related to MC58 and the other to M01573. The second aspect introduces a multi-family fHbp-based vaccine that combines a family I fHbp sequence, more closely related to MC58, with a family III fHbp sequence. Another notable patent by Aricò is the hybrid expression of Neisserial proteins. This patent describes the expression of two or more Neisserial proteins as a single hybrid protein, represented by the formula NH-A-B—COOH.

Career Highlights

Throughout her career, Maria Aricò has worked with leading pharmaceutical companies, including GlaxoSmithKline Biologicals and Novartis AG. Her work in these organizations has allowed her to contribute to groundbreaking research and development in the field of vaccines.

Collaborations

Maria has collaborated with esteemed colleagues such as Maurizio Comanducci and Mariagrazia Pizza. These partnerships have further enhanced her research and innovation in vaccine technology.

Conclusion

Maria Aricò's work exemplifies the vital role of inventors in advancing public health through innovative vaccine solutions. Her patents reflect a commitment to improving meningococcal vaccine coverage and efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…